Marek Wloch
Impact in
- Oncology top 10%
- Cytokine Signaling Pathways and Interactions
- HER2/EGFR in Cancer Research
Papers in
-
- Protein Kinase Regulation and GTPase Signaling 4
- Oncology 5
- Bone health and treatments 3
- Cytokine Signaling Pathways and Interactions 2
- Co-authors
- Richard Jove (2 shared papers)Roy Garcia (2 shared papers)Timothy J. Yeatman (3 shared papers)Weiguang Mao (3 shared papers)Rosalyn Irby (2 shared papers)Alan Cantor (2 shared papers)Peter Vadas (7 shared papers)Ling Fu (1 shared paper)
- Journals
- Journal of Clinical Oncology (1 paper)Clinical Cancer Research (1 paper)Lung Cancer (1 paper)Clinical & Experimental Immunology (1 paper)Clinical & Experimental Metastasis (1 paper)
- Partner nations
- United StatesCanadaUnited Kingdom
In The Last Decade
Marek Wloch
16 papers receiving 624 citations
Peers
Comparison fields: 5 of 70
- Oncology 258
- Cancer Research 95
- Pathology and Forensic Medicine 106
- Immunology and Allergy 33
- Molecular Biology 308
Countries citing papers authored by Marek Wloch
This map shows the geographic impact of Marek Wloch's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marek Wloch with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marek Wloch more than expected).
Fields of papers citing papers by Marek Wloch
This network shows the impact of papers produced by Marek Wloch. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marek Wloch. The network helps show where Marek Wloch may publish in the future.
Co-authors
The 25 scholars most cited alongside Marek Wloch, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2006 | 205 | |
| 2 | 1997 | 171 | |
| 3 | Analysis of colorectal cancer by comparative genomic hybridization: evidence for induction of the metastatic phenotype by loss of tumor suppressor genes. | 1998 | 63 |
| 4 | 2001 | 53 | |
| 5 | 1996 | 38 | |
| 6 | 1991 | 20 | |
| 7 | Synthesis and release of phospholipase A2 by unstimulated human articular chondrocytes. | 1990 | 18 |
| 8 | The role of phospholipase A2 in the physiopathology of osteoarthritis. | 1991 | 15 |
| 9 | 1996 | 14 | |
| 10 | Induction of release of secretory nonpancreatic phospholipase A2 from human articular chondrocytes. | 1995 | 12 |
| 11 | Helicobacter pylori in liver diseases. | 2006 | 8 |
| 12 | 1997 | 7 | |
| 13 | 1995 | 3 | |
| 14 | 2017 | 2 | |
| 15 | 2022 | 1 | |
| 16 | 2019 | 1 |
About Marek Wloch
Marek Wloch is a scholar working on Molecular Biology, Oncology, Cancer Research, Surgery and Pathology and Forensic Medicine, having authored 16 papers that have together received 631 indexed citations. Recurring topics across this work include Protein Kinase Regulation and GTPase Signaling (4 papers), Bone health and treatments (3 papers), Genetic factors in colorectal cancer (3 papers), Cancer Genomics and Diagnostics (2 papers), Osteoarthritis Treatment and Mechanisms (2 papers), Inflammatory mediators and NSAID effects (2 papers), Cytokine Signaling Pathways and Interactions (2 papers) and Protease and Inhibitor Mechanisms (2 papers). The work is most often cited by research in Oncology (258 citations), Cancer Research (95 citations), Pathology and Forensic Medicine (106 citations), Immunology and Allergy (33 citations) and Molecular Biology (308 citations). Marek Wloch has collaborated with scholars based in United States, Canada and United Kingdom. Frequent co-authors include Richard Jove, Roy Garcia, Timothy J. Yeatman, Weiguang Mao, Rosalyn Irby, Alan Cantor, Peter Vadas, Ling Fu, Domenico Coppola and Hua Yu. Their work appears in journals such as Journal of Clinical Oncology, Clinical Cancer Research, Lung Cancer, Clinical & Experimental Immunology and Clinical & Experimental Metastasis.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.